Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H17N5O2 |
| Molecular Weight | 323.3492 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(CNC2=CC=C(C=C2)C(N)=N)=NC3=C1C=CC(=C3)C(O)=O
InChI
InChIKey=PLWQWQUVUDJPFA-UHFFFAOYSA-N
InChI=1S/C17H17N5O2/c1-22-14-7-4-11(17(23)24)8-13(14)21-15(22)9-20-12-5-2-10(3-6-12)16(18)19/h2-8,20H,9H2,1H3,(H3,18,19)(H,23,24)
| Molecular Formula | C17H17N5O2 |
| Molecular Weight | 323.3492 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:55:20 GMT 2025
by
admin
on
Wed Apr 02 07:55:20 GMT 2025
|
| Record UNII |
K37YZW4JU4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
69624070
Created by
admin on Wed Apr 02 07:55:20 GMT 2025 , Edited by admin on Wed Apr 02 07:55:20 GMT 2025
|
PRIMARY | |||
|
K37YZW4JU4
Created by
admin on Wed Apr 02 07:55:20 GMT 2025 , Edited by admin on Wed Apr 02 07:55:20 GMT 2025
|
PRIMARY | |||
|
1015167-27-7
Created by
admin on Wed Apr 02 07:55:20 GMT 2025 , Edited by admin on Wed Apr 02 07:55:20 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
TRACE AMOUNT
PLASMA
|
||
|
PARENT -> METABOLITE |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
FECAL
|
||
|
PARENT -> METABOLITE |
after i.v. infusion of 5 mg of 14C dabigatran in healthy volunteers
URINE
|
||
|
PARENT -> METABOLITE |
after i.v. infusion of 5 mg of 14C dabigatran in healthy volunteers
FECAL
|
||
|
PARENT -> METABOLITE |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
URINE
|
||
|
PARENT -> METABOLITE |
after i.v. infusion of 5 mg of 14C dabigatran in healthy volunteers
TRACE AMOUNT
PLASMA
|
